Swiss
-
News
Swiss. New work organization models in Novartis and Roche
“My company helps companies to overcome traditional hierarchical models”. So Francesco Frugiuele, co-founder of "KopernicanaExternal link" enters…
Leggi » -
News
Swiss. Cluster of roles: Severin Schwan, CEO of Roche, will step down as Vice President of Credit Suisse
Credit Suisse Vice Chairman Schwan Leaves Board From: Reuters - Published: Mar 21, 2022 ZURICH (Reuters) - Credit Suisse has announced that…
Leggi » -
News
Referendum in Switzerland. Animal testing will continue to be permitted
The Swiss people rejected the initiative calling for a ban on all experiments on animals and humans by a large majority. There…
Leggi » -
News
International transporters union accuses EU, Great Britain and Switzerland on the issue of vaccine patents
Unions accuse, Switzerland defends Big Pharma TV Switzerland – 14 October 2021 International transport unions accuse Switzerland…
Leggi » -
News
Swiss. Transparency in the lobbying activity of deputies. The pharmaceutical industry appears underrepresented
Richest lobbies invest money in MPs SwissInfo – 5 September 2021 Industries of various economic sectors have the…
Leggi » -
News
Swiss. They cheated Roche, convicted
Thirty-nine and 51 months in prison for having stolen 10 million from the multinational thanks to accounting tricks RSI News –…
Leggi » -
News
Pharmaceutical production: Switzerland first in Europe, Italy first in the EU
Although Swiss pharmaceutical production is the first in Europe, with a turnover of over 46 billion euros in…
Leggi » -
First floor
Swiss. There is a lack of patent-expired drugs. Branded companies are no longer convenient and China, which produces generics for the whole world, is unable to meet the demands
There is a shortage of (certain) medicines in Switzerland Swiss TV – 10 June 2019 In Switzerland, home to some of the…
Leggi » -
News
Swiss. Money from “Big Pharma” to doctors
More than 12 million francs were disbursed in 2017, even anonymously. The complaint: “This affects the prescriptions” RSI…
Leggi » -
News
Swiss. Compulsory licenses against 'expensive medicines'?
The problem of access to "vital medicines" no longer concerns only developing countries, but also the rich…
Leggi »